VanEck Vectors Net Asset

VanEck Vectors Biotech ETF -- USA Etf  

USD 120.11  3.04  2.47%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Net Asset Analysis

Net Asset is current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assest is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
VanEck Vectors 
Net Asset 
Current Market Value 
Current Liabilities 
549.72 M

About Net Asset

Net Asset is the value used in calulating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formullay that uses closing prices of all positions in the fund's portfolio.
Compare to competition
Based on recorded statements VanEck Vectors Biotech ETF has Net Asset of 549.72 M. This is 71.07% higher than that of the Van Eck family, and significantly higher than that of Sector category, The Net Asset for all etfs is 38.15% higher than the company.

Peer Comparison

VanEck Vectors Net Asset Comparison
  Net Asset 
      VanEck Vectors Comparables 
VanEck Vectors is currently under evaluation in net asset as compared to similar ETFs.

Did you try this?

Run Commodity Channel Index Now

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
Hide  View All  NextLaunch Commodity Channel Index

Asset Allocation

Fund Instrument Allocation for VanEck Vectors
The fund invests 99.99% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.
      Instrument Type 

Fundamental Indicators

Current VanEck Vectors financial ratios